LMTK3 Activators
The class of chemicals known as LMTK3 Activators includes compounds that could potentially influence the activity of LMTK3 indirectly by modulating related signaling pathways and cellular processes. These chemicals do not activate LMTK3 directly but impact various biochemical and cellular pathways, creating conditions that may favor LMTK3's activity.
Compounds like Forskolin and IBMX, which affect cAMP levels, could potentially influence signaling cascades that modulate LMTK3's function. These changes in intracellular signaling could alter the cellular context in which LMTK3 operates, potentially enhancing its activity. Similarly, agents like PMA that activate PKC and A-83-01, a TGF-β receptor inhibitor, might also indirectly influence pathways involving LMTK3. Kinase inhibitors such as U0126, PD98059, LY294002, and SB203580, though primarily inhibitory in their direct actions, can create a cascade of signaling alterations that might affect LMTK3. By modulating pathways such as ERK/MAPK, PI3K, and p38 MAPK, these chemicals could indirectly impact the functional context of LMTK3.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Activates adenylyl cyclase, increasing cAMP levels, which could influence signaling pathways related to LMTK3's activity. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
A non-specific inhibitor of phosphodiesterases, elevating cAMP and cGMP levels, potentially affecting signaling pathways related to LMTK3. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
Activates protein kinase C (PKC), potentially influencing signaling cascades that could modulate LMTK3 activity. | ||||||
A 83-01 | 909910-43-6 | sc-203791 sc-203791A | 10 mg 50 mg | $202.00 $811.00 | 16 | |
A TGF-β receptor inhibitor, potentially affecting pathways that could indirectly influence LMTK3 activity. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
Another MEK inhibitor, influencing the ERK/MAPK pathway, could indirectly modulate LMTK3 activity. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
A PI3K inhibitor, potentially influencing signaling pathways that could affect LMTK3 activity. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
An mTOR inhibitor, could influence signaling pathways related to LMTK3's role in cell growth and proliferation. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
A p38 MAPK inhibitor, potentially affecting signaling pathways related to LMTK3 activity. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $186.00 $707.00 | 88 | |
A ROCK inhibitor, could influence cytoskeletal dynamics and signaling pathways related to LMTK3. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
An inhibitor of JNK, potentially influencing signaling pathways that intersect with LMTK3's role in the cell. | ||||||